KNOWLEDGE, PRACTICES AND ATTITUDES OF GENERAL PRACTITIONERS TOWARDS IRRITABLE BOWEL SYNDROME: A CROSS SECTIONAL STUDY

Main Article Content

Jibran Umar Ayub Khan
Junaid Ahsan
Adil Shah Roghani
Saba Gul
Aiman Salim
Abdul Wahab

Keywords

.

Abstract

Background: Irritable bowel syndrome (IBS) is a functional bowel disorder that has colossal impact on the quality of life while the patient’s views have been explored in detail in a large no. of studies the opinions of the general physicians need to explored as they are primary route of referral to medical specialists


Objective: To assess knowledge, practices and attitudes of general practitioners towards irritable bowel syndrome


Materials and Methods: This cross sectional study was conducted in Peshawar after the approval of research proposal by research committee of MMC General Hospital Peshawar 15th January 2023 t0 15th June 2023  .The inclusion criteria was general practitioners working in different clinics and hospitals The medical specialists and gastroenterologists were excluded from the study Total sample size was 100  with non-probability convenient sampling as the technique . The participants were asked to fill a questionnaire after explaining the pros and con the study. The data analysis was done by SPSS version 22.  The frequencies and percentages were applied for categorical data where as Mean and SD were applied for quantitative data. The Chi Square test was applied taking a p value of 0.05 or less as significant


Results: The mean age of the respondents was 38 years with equal male to female ratio .58% of the general practitioners were from urban areas while rest of them were from rural settings. The knowledge questions were assessed by true, false and don’t know. Regarding IBS a hereditary disease 44% admitted it to be true, 25% false and 31% don’t know. IBS affects only women with rue responses 48%,32% false and 20% saying don’t know. IBS is a life-threatening disease 51% said to be true.27% false and 22%  don’t know. IBS symptoms affects the patients daily life with true responses about 43%, false 34% and 23% don’t know . Regarding practices and answering Do you take your medications prescribed for IBS regularly? 58% said yes and 42% said No, Do you avoid gluten containing products (wheat ,barley and rye) containing food products that might worsen your symptoms? 65% Yes and 35% No, Do you perform yoga 48% yes and 52% No. The responses of the participants in terms of their attitudes towards IBS can be seen in tables below. Significant association for responses of the participants for After following advice from your physician regarding diet, life style, and medications, do you feel that your daily life is less affected now with a p value of 0.03


Conclusion: This study concluded that general practitioners had satisfactory level of awareness about the disease and that is a good omen for appropriate referral and management by the trained physicians and experts in the field

Abstract 121 | PDF Downloads 94

References

1. Rej A, Avery A, Aziz I, Black CJ, Bowyer RK, Buckle RL, et al. Diet and irritable bowel syndrome: an update from a UK consensus meeting. BMC Med [Internet]. 2022;20(1):1–11. Available from: https://doi.org/10.1186/s12916-022-02496-w
2. Chen Y, Lian B, Li P, Yao S, Hou Z. Studies on irritable bowel syndrome associated with anxiety or depression in the last 20 years: A bibliometric analysis. Front Public Heal. 2022;10.
3. Moayyedi P, Mearin F, Azpiroz F, Andresen V, Barbara G, Corsetti M, et al. Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice. United Eur Gastroenterol J. 2017;5(6):773–88.
4. Tai D. This is a repository copy of Diagnostic yield of colonoscopy in patients with symptoms compatible with Rome IV functional bowel disorders . White Rose Research Online URL for this paper : Version : Accepted Version Article : Asghar , Z ., Thoufeeq , M ., . 2022;
5. Talley NJ, Zand Irani M. Optimal management of severe symptomatic gastroesophageal reflux disease. J Intern Med. 2021;289(2):162–78.
6. MacFarlane B. Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective. Integr Pharm Res Pract. 2018;Volume 7:41–52.
7. Vajravelu RK, Shapiro JM, Ni J, Thanawala SU, Lewis JD, El-Serag HB. Risk for Post-Colonoscopy Irritable Bowel Syndrome in Patients With and Without Antibiotic Exposure: A Retrospective Cohort Study. Clin Gastroenterol Hepatol [Internet]. 2022;20(6):e1305–22. Available from: https://doi.org/10.1016/j.cgh.2021.08.049
8. Törnblom H, Goosey R, Wiseman G, Baker S, Emmanuel A. Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: Results from patient and healthcare professional surveys. United Eur Gastroenterol J. 2018;6(9):1417–27.
9. Algabr GA, Alotaibi TK, Alshaikh AM. Assessment of Knowledge, Attitude and Practice towards Irritable Bowel Syndrome and Risk Factors in Riyadh City, 2017. Egypt J Hosp Med. 2018;70(8):1377–80.
10. Bradley S, Alderson S, Ford AC, Foy R. General practitioners’ perceptions of irritable bowel syndrome: A Q-methodological study. Fam Pract. 2018;35(1):74–9.
11. Austhof E, Schaefer K, Faulkner J, Bach L, Riddle M, Pogreba-Brown K. Knowledge and practices of primary care physicians or general practitioners treating post-infectious Irritable Bowel Syndrome. BMC Gastroenterol. 2020;20(1):1–6.
12. McGhie-Fraser B, Lucassen P, Ballering A, Abma I, Brouwers E, van Dulmen S, et al. Persistent somatic symptom related stigmatisation by healthcare professionals: A systematic review of questionnaire measurement instruments. J Psychosom Res [Internet]. 2023;166(October 2022):111161. Available from:
https://doi.org/10.1016/j.jpsychores.2023.111161
13. Ceccherini C, Daniotti S, Bearzi C, Re I. Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi‐Criteria Decision Analysis. Nutrients. 2022;14(13).

Most read articles by the same author(s)